Reuters | Reuters India | Reuters News | Reuters World News | Reuters News Online | Reuters India News | Latest Reuters News

Reuters-News

Current Headlines | Most Read | Archives

J&J plans filing on more than 10 new drugs by 2017 (23 May 06:01 pm)

(Reuters) - Johnson & Johnson said on Thursday it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis C, immune diseases and schizophrenia,

BTG says interventional medicine buys could boost sales to $1 bln (23 May 05:37 pm)

LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion.

Saudi Arabia confirms another death from SARS-like virus (23 May 05:31 pm)

DUBAI (Reuters) - Saudi Arabia has announced another death from the SARS-like novel coronavirus (nCoV) in its central al-Qassim region, bringing the total number of deaths in the kingdom to 17.

GSK flu shot may raise adult narcolepsy risk: Finnish scientists (23 May 04:43 pm)

HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc\'s H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland\'s National

Pfizer takes its shot at a vaccine for evasive superbug (23 May 10:58 am)

CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the

Merck's insomnia drug moves a step closer to U.S. approval (23 May 06:32 am)

WASHINGTON (Reuters) - Merck & Co\'s experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses.

Senate committee advances drug compounding bill (23 May 04:28 am)

NEW YORK (Reuters) - A U.S. Senate committee on Wednesday unanimously approved legislation that would increase federal oversight for companies that compound and sell sterile drugs across state lines.

FDA panel says Merck's sleep drug safe, effective at lower dose (23 May 04:27 am)

WASHINGTON (Reuters) - Merck & Co\'s experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it will be

Health officials probe deadly respiratory illness in Alabama (23 May 03:19 am)

BIRMINGHAM, Alabama (Reuters) - U.S. and state health authorities are investigating an unidentified respiratory illness that has killed two of 10 people hospitalized with it in Alabama since last

FDA panel: Merck's insomnia drug effective, safe at low doses (23 May 03:01 am)

WASHINGTON (Reuters) - Merck & Co\'s experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday.

Online tool helps control blood pressure long term (23 May 02:43 am)

NEW YORK (Reuters Health) - In a new study, people with high blood pressure who could communicate with their pharmacists online had better blood pressure control a year after that service ended.

Vitamin C may not treat gout: study (23 May 02:07 am)

NEW YORK (Reuters Health) - Daily vitamin C supplements don\'t lower uric acid as much as drugs used to treat high levels of the acid that\'s responsible for gout, says a new study from New Zealand.

Sugary drinks tied to kidney stone risk (23 May 01:38 am)

NEW YORK (Reuters Health) - Adults who drink at least one sugar-sweetened drink a day are slightly more likely to develop kidney stones than people who rarely imbibe them, according to a new study.

More patients than docs report skin surgery problems (23 May 01:04 am)

NEW YORK (Reuters Health) - More than one quarter of people being treated for non-melanoma skin cancer in their doctor\'s office reported some type of complication after surgery, in a new study.

Thrifty Merrimack developing new cancer drugs at lower cost (23 May 12:29 am)

NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction of the

Los Angeles voters approve limiting medical marijuana shops (22 May 11:58 pm)

LOS ANGELES (Reuters) - Los Angeles, which has more storefront medical marijuana shops than any other U.S. city, will close hundreds of the dispensaries and hike taxes on those that will be allowed to

Swiss billionaires buy Merck Serono HQ for biotech campus (22 May 07:23 pm)

ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus.

Oncolytics cancer drug meets mid-stage trial goal, shares rise (22 May 07:16 pm)

(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic

When it comes to deadly viruses, what's in a name? (22 May 06:24 pm)

LONDON (Reuters) - For a pathogen with such a short history, the mysterious new virus killing people in the Middle East and Europe has already had an amazing array of names.

Pfizer to spin off Zoetis stake to shareholders (22 May 06:22 pm)

(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent

U.S. government taps GlaxoSmithKline for new antibiotics (22 May 04:50 pm)

LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism.

Los Angeles voters OK move to curtail medical marijuana outlets (22 May 04:24 pm)

LOS ANGELES (Reuters) - Voters strongly supported a ballot measure to sharply curtail the number of medical marijuana dispensaries permitted to operate in Los Angeles while boosting taxes on the sale

Immune system cancer drugs tipped to be a $35 billion market (22 May 03:18 pm)

LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year.

Merck signs $5 billion share buyback agreement with Goldman Sachs (22 May 11:37 am)

(Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the drug giant looks to prop up shareholder value in face of stiff

Amag investigates anemia drug after report of death in Switzerland (22 May 06:13 am)

(Reuters) - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag\'s anemia drug, Rienso, because of a death and several cases